Summary & Overview

HCPCS G6053: Methadone Medication Therapy

HCPCS Level II code G6053 identifies methadone, an opioid agonist medication used in medication-assisted treatment and pain management. Nationally, methadone is a key component of opioid use disorder treatment programs and represents an important category of reimbursable pharmacologic therapy in ambulatory and specialty clinic settings. Clear coding for methadone supports continuity of care, accurate reporting, and claims processing for substance use disorder services.

Key payers in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of coverage and billing context across major national payers, typical sites of service where G6053 is used, and benchmarks for coding frequency and utilization when available. The publication also summarizes relevant policy updates that affect reimbursement and clinical documentation expectations, and provides clinical context around methadone use in treatment programs.

This summary is intended to inform clinicians, billing professionals, and policy analysts about the role of HCPCS Level II code G6053 in national billing practice, coverage considerations among major payers, and the clinical settings where methadone is commonly administered.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicareG6053HCPCS Level IIMethadoneMedication-assisted treatmentOpioid use disorderOutpatientAmbulatory care

Billing Code Overview

HCPCS Level II code G6053 denotes Methadone. This code represents the provision or administration of methadone as a pharmacologic treatment.

Service type: Medication therapy (opioid agonist pharmacotherapy)
Typical site of service: Outpatient clinics, medication-assisted treatment (MAT) programs, and other ambulatory settings where methadone is dispensed or administered

Clinical & Coding Specifications

Clinical Context

A typical patient is an adult with opioid use disorder (OUD) enrolled in a federally certified opioid treatment program (OTP) for medication-assisted treatment (MAT). The patient presents to the clinic for supervised administration of methadone, requiring daily observed dosing due to regulatory and safety considerations. Clinical workflow: intake with review of diagnosis and treatment plan, verification of patient identity and prescription, nursing intake including vital signs and brief mental-status check, supervised oral administration of G6053 (methadone) on site, documentation of dose, and scheduling of the next supervised dose. Ancillary activities can include brief counseling by clinic staff, toxicology testing as ordered, and coordination with the prescribing physician for dose adjustments.

Coding Specifications

Modifier	Description	When to Use
`TC`	Technical component	Use when billing only the technical component of a service; for `G6053`, `TC` may be applied if the claim is for the facility/clinic supply/administration portion only and payer policy allows.
`25`	Significant, separately identifiable evaluation and management service by the same physician on the same day	Use when a separately identifiable E/M visit is provided on the same day as supervised methadone dosing and documentation supports a distinct service.
`59`	Distinct procedural service	Use when another distinct, unrelated service is performed the same day and must be reported separately from the methadone administration.
`76`	Repeat procedure by same provider	Use when the same service (e.g., supervised dosing encounter) is repeated within the same day and needs separate reporting as allowed by payer.
`77`	Repeat procedure by another provider	Use when a repeat supervised administration is performed by a different provider on the same day.
`91`	Repeat clinical diagnostic laboratory test	Use when repeat toxicology testing related to MAT is performed and reported separately from the methadone administration.
`GQ`	Telehealth — asynchronous exchange of information	Use when components of counseling or monitoring related to MAT are delivered via asynchronous telehealth as permitted by payer policy.
`GT`	Via interactive audio and video telecommunications	Use when counseling or supervision components related to MAT are delivered live via telehealth during the same encounter as allowed.
`XE`	Separate encounter (subset of modifier 59)	Use when the methadone administration occurs at a separate encounter from another service and distinct reporting is required.
`XS`	Separate structure (subset of modifier 59)	Use when services are performed on a different anatomical site or system and separate reporting is required.

Taxonomy Code	Specialty	Notes
208D00000X	Addiction Medicine	Physicians who manage medication-assisted treatment and methadone dosing oversight.
208000000X	Family Medicine	Primary care physicians providing MAT or coordinating OTP services.
208000000X	Internal Medicine	Internists involved in long-term management of OUD and methadone therapy.
101YM0800X	Certified Substance Use Disorder Counselor	Behavioral health providers who deliver counseling as part of OTP programs.
367A00000X	Nurse Practitioner	NPs who may manage dosing coordination and perform supervised administration in clinic settings.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`F11.20`	Opioid dependence, uncomplicated	Primary diagnosis for patients receiving methadone as medication-assisted treatment.
`F11.21`	Opioid dependence, in remission	Used when a patient in MAT shows sustained remission but continues maintenance therapy under supervision.
`F11.10`	Opioid abuse, uncomplicated	May be used in contexts where methadone is part of a treatment plan for opioid use disorder not yet meeting dependence criteria in documentation.
`Z79.899`	Other long term (current) drug therapy	Used to indicate chronic opioid substitution therapy such as ongoing methadone maintenance.
`F19.20`	Other psychoactive substance dependence, uncomplicated	Included when polysubstance use disorder coexists and impacts monitoring and dosing decisions.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`99401`	Preventive medicine counseling and/or risk factor reduction intervention(s); approximately 15 minutes	Used for brief counseling sessions that may accompany MAT visits in outpatient settings when billed separately.
`99402`	Preventive medicine counseling and/or risk factor reduction intervention(s); approximately 30 minutes	Used for longer counseling sessions provided in conjunction with methadone treatment when documentation supports time and content.
`80305`	Drug test, presumptive, any number of drug classes; any number by instrumented chemistry analyzers	Commonly performed for monitoring adherence and illicit substance use in patients receiving methadone.
`80306`	Drug test, definitive, each drug class method; chromatographic/TLC, GC/MS, or LC/MS/MS	Used when confirmatory toxicology testing is required in OTP monitoring protocols.
`99213`	Office or other outpatient visit for the evaluation and management of an established patient, typically 15 minutes	Used for routine follow-up visits with the prescribing clinician to assess methadone efficacy, safety, and dosing.